Register for SOSV Deep Tech Live – Dr. Rick Gottscho on Plasma & Semiconductors

Leading the Future in Point of Care Diagnostics

InnSight Technology

Company details

Our company is dedicated to translational research initiatives that will advance diagnostics and evaluation of eye and systemic disease. Our primary focus is to provide an objective measurement of tear fluid biomarkers to standardize treatment solutions not only for dry eye but for systemic disease. We are an innovative tear fluid analytic company enabling detection of hard to diagnose diseases by collecting and analyzing tear fluid in a non-invasive way.

Get In Touch with InnSight Technology

Please tell us a little bit about yourself and why you'd like to get connected. InnSight Technology + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More